165 related articles for article (PubMed ID: 34871638)
21. Opioid and Cannabis Co-Use among Adults With Chronic Pain: Relations to Substance Misuse, Mental Health, and Pain Experience.
Rogers AH; Bakhshaie J; Buckner JD; Orr MF; Paulus DJ; Ditre JW; Zvolensky MJ
J Addict Med; 2019; 13(4):287-294. PubMed ID: 30557213
[TBL] [Abstract][Full Text] [Related]
22. Treatment utilization among persons with opioid use disorder in the United States.
Wu LT; Zhu H; Swartz MS
Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
[TBL] [Abstract][Full Text] [Related]
23. Comorbid Prolonged Grief, PTSD, and Depression Trajectories for Bereaved Family Surrogates.
Wen FH; Prigerson HG; Chou WC; Huang CC; Hu TH; Chiang MC; Chuang LP; Tang ST
JAMA Netw Open; 2023 Nov; 6(11):e2342675. PubMed ID: 37948078
[TBL] [Abstract][Full Text] [Related]
24. Latent classes of symptom trajectories among major depressive disorder patients in China.
Wang Y; Li J; Bian W; Duan Y; Geng W; Jiang J; Zhao X; Li T; Jiang Y; Shi L; Cao J; Zhu G; Zhang K; Chen Q; Tian H; Wang X; Zhang N; Wang G; Wei J; Yu X
J Affect Disord; 2024 Apr; 350():746-754. PubMed ID: 38246287
[TBL] [Abstract][Full Text] [Related]
25. Predictors and Functional Outcomes Associated With Longitudinal Trajectories of Anxiety and Depression from 2 to ≥36 Months After Moderate to Severe Traumatic Brain Injury.
Heath LM; Kidwai MR; Colella B; Monette G; Tselichtchev P; Tomaszczyk JC; Green RE
J Neurotrauma; 2023 Nov; 40(21-22):2311-2320. PubMed ID: 36927109
[TBL] [Abstract][Full Text] [Related]
26. Multi-level predictors of psychological problems among methadone maintenance treatment patients in difference types of settings in Vietnam.
Le TA; Le MQT; Dang AD; Dang AK; Nguyen CT; Pham HQ; Vu GT; Hoang CL; Tran TT; Vuong QH; Tran TH; Tran BX; Latkin CA; Ho CSH; Ho RCM
Subst Abuse Treat Prev Policy; 2019 Sep; 14(1):39. PubMed ID: 31533764
[TBL] [Abstract][Full Text] [Related]
27. Differential Experience of Interdose Withdrawal During Long-Term Opioid Therapy and its Association With Patient and Treatment Characteristics: A Latent Class Analysis in Chronic Pain Population.
Rodríguez-Espinosa S; Coloma-Carmona A; Pérez-Carbonell A; Román-Quiles JF; Carballo JL
J Pain; 2022 Aug; 23(8):1427-1436. PubMed ID: 35429674
[TBL] [Abstract][Full Text] [Related]
28. Effects of Early Life Trauma on Risks for Adult Opioid Use Disorder Are Mediated by Stress and Occur Independent of Depression and Anxiety.
Dunn KE; Turner GM; Oswald LM
J Addict Med; 2022 Nov-Dec 01; 16(6):709-715. PubMed ID: 35914024
[TBL] [Abstract][Full Text] [Related]
29. Mood and suicidality outcomes 3-11 years following pediatric anxiety disorder treatment.
Keeton CP; Caporino NE; Kendall PC; Iyengar S; Lee P; Peris T; Sakolsky D; Piacentini J; Compton SN; Albano AM; Birmaher B; Ginsburg GS
Depress Anxiety; 2019 Oct; 36(10):930-940. PubMed ID: 31356713
[TBL] [Abstract][Full Text] [Related]
30. The identification of symptom-based subtypes of depression: A nationally representative cohort study.
Ten Have M; Lamers F; Wardenaar K; Beekman A; de Jonge P; van Dorsselaer S; Tuithof M; Kleinjan M; de Graaf R
J Affect Disord; 2016 Jan; 190():395-406. PubMed ID: 26546775
[TBL] [Abstract][Full Text] [Related]
31. Cannabis use moderates the relationship between pain and negative affect in adults with opioid use disorder.
Wilson M; Gogulski HY; Cuttler C; Bigand TL; Oluwoye O; Barbosa-Leiker C; Roberts MA
Addict Behav; 2018 Feb; 77():225-231. PubMed ID: 29078148
[TBL] [Abstract][Full Text] [Related]
32. Trajectories of depression and anxiety symptoms during the COVID-19 pandemic in a representative Australian adult cohort.
Batterham PJ; Calear AL; McCallum SM; Morse AR; Banfield M; Farrer LM; Gulliver A; Cherbuin N; Rodney Harris RM; Shou Y; Dawel A
Med J Aust; 2021 Jun; 214(10):462-468. PubMed ID: 33899939
[TBL] [Abstract][Full Text] [Related]
33. Opioid use and dependence among persons with migraine: results of the AMPP study.
Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB
Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775
[TBL] [Abstract][Full Text] [Related]
34. Parallel modeling of pain and depression in prediction of relapse during buprenorphine and naloxone treatment: A finite mixture model.
Vest NA; McPherson S; Burns GL; Tragesser S
Drug Alcohol Depend; 2020 Apr; 209():107940. PubMed ID: 32135429
[TBL] [Abstract][Full Text] [Related]
35. Nonmedical Use of Prescription Opioids among Pregnant U.S. Women.
Kozhimannil KB; Graves AJ; Levy R; Patrick SW
Womens Health Issues; 2017; 27(3):308-315. PubMed ID: 28408072
[TBL] [Abstract][Full Text] [Related]
36. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
37. Associations of mental health and family background with opioid analgesic therapy: a nationwide Swedish register-based study.
Quinn PD; Rickert ME; Franck J; Sariaslan A; Boersma K; Lichtenstein P; Larsson H; D'Onofrio BM
Pain; 2019 Nov; 160(11):2464-2472. PubMed ID: 31339870
[TBL] [Abstract][Full Text] [Related]
38. Developmental trajectories of anxiety and depression in early adolescence.
McLaughlin KA; King K
J Abnorm Child Psychol; 2015 Feb; 43(2):311-23. PubMed ID: 24996791
[TBL] [Abstract][Full Text] [Related]
39. Polysubstance Use, Mood Disorders, and Chronic Conditions With Anxiety in Opioid Patients.
Liu S; Nwabueze C; Pan Y; Walter SM; Su B; Xu C; Winstanley EL; Wang K
West J Nurs Res; 2022 Dec; 44(12):1088-1099. PubMed ID: 34301163
[TBL] [Abstract][Full Text] [Related]
40. Long-term recovery from opioid use disorder: recovery subgroups, transition states and their association with substance use, treatment and quality of life.
Craft WH; Shin H; Tegge AN; Keith DR; Athamneh LN; Stein JS; Ferreira MAR; Chilcoat HD; Le Moigne A; DeVeaugh-Geiss A; Bickel WK
Addiction; 2023 May; 118(5):890-900. PubMed ID: 36524904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
